Lineage Cell Therapeutics, Inc. (LCTX) has released an update.
Lineage Cell Therapeutics, Inc. is gearing up for its 2024 annual shareholder meeting on June 11, earlier than usual. Shareholders keen on proposing business or nominating directors must notify the company by March 15, while those looking to include proposals in the proxy statement have until March 29. Proposals must adhere to the company bylaws and securities regulations, and be sent to the corporate secretary at the company’s Carlsbad office. This allows ample time for the company to prepare and distribute the meeting materials.
For further insights into LCTX stock, check out TipRanks’ Stock Analysis page.
